NDC 51167-500

ORKAMBI

Lumacaftor And Ivacaftor

ORKAMBI is a Oral Granule in the Human Prescription Drug category. It is labeled and distributed by Vertex Pharmaceuticals Incorporated. The primary component is Ivacaftor; Lumacaftor.

Product ID51167-500_2412d19f-9f31-49f3-a7f9-f44db330fcf7
NDC51167-500
Product TypeHuman Prescription Drug
Proprietary NameORKAMBI
Generic NameLumacaftor And Ivacaftor
Dosage FormGranule
Route of AdministrationORAL
Marketing Start Date2018-08-07
Marketing CategoryNDA / NDA
Application NumberNDA211358
Labeler NameVertex Pharmaceuticals Incorporated
Substance NameIVACAFTOR; LUMACAFTOR
Active Ingredient Strength188 mg/1; mg/1
Pharm ClassesChloride Channel Activation Potentiators [MoA], Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inducers [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 51167-500-02

56 PACKET in 1 CARTON (51167-500-02) > 1 GRANULE in 1 PACKET
Marketing Start Date2018-08-07
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51167-500-02 [51167050002]

ORKAMBI GRANULE
Marketing CategoryNDA
Application NumberNDA211358
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-08-07

Drug Details

Active Ingredients

IngredientStrength
LUMACAFTOR150 mg/1

OpenFDA Data

SPL SET ID:3fc1c40e-cfac-47a1-9e1a-61ead3570600
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1655928
  • 2053519
  • 2053509
  • 1655934
  • 1812470
  • 2053512
  • 2053517
  • 1812468
  • Pharmacological Class

    • Cytochrome P450 3A Inducers [MoA]
    • Cytochrome P450 2B6 Inducers [MoA]
    • Cytochrome P450 2C8 Inducers [MoA]
    • Cytochrome P450 2C9 Inducers [MoA]
    • Cytochrome P450 2C19 Inducers [MoA]
    • Cytochrome P450 2C8 Inhibitors [MoA]
    • Cytochrome P450 2C9 Inhibitors [MoA]
    • P-Glycoprotein Inducers [MoA]
    • P-Glycoprotein Inhibitors [MoA]
    • Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]
    • Chloride Channel Activation Potentiators [MoA]
    • Cytochrome P450 3A4 Inhibitors [MoA]
    • Cytochrome P450 2C9 Inhibitors [MoA]
    • P-Glycoprotein Inhibitors [MoA]
    • Cytochrome P450 3A Inhibitors [MoA]

    NDC Crossover Matching brand name "ORKAMBI" or generic name "Lumacaftor And Ivacaftor"

    NDCBrand NameGeneric Name
    51167-122ORKAMBIlumacaftor and ivacaftor
    51167-500ORKAMBIlumacaftor and ivacaftor
    51167-700ORKAMBIlumacaftor and ivacaftor
    51167-809ORKAMBIlumacaftor and ivacaftor
    51167-900ORKAMBIlumacaftor and ivacaftor

    Trademark Results [ORKAMBI]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ORKAMBI
    ORKAMBI
    86399751 4828608 Live/Registered
    Vertex Pharmaceuticals Incorporated
    2014-09-19
    ORKAMBI
    ORKAMBI
    86179790 4822946 Live/Registered
    Vertex Pharmaceuticals Incorporated
    2014-01-30

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.